SkinPass™ Technology
Next-Generation Transdermal
Drug Delivery Platform
Deeper, faster delivery for topical medications — throughout the entire lesion.
Scientifically Validated
Clinically Supported Technology
Patent Protected
U.S. Patent 12,465,567
Engineered for Superior Results
Advanced Delivery. Better Outcomes.
How SkinPass™ Works
Patented Faster Absorption
and Penetration
Unlike traditional topicals that primarily remain on the skin surface, SkinPass™ uses a clinically proven mixture of physical and chemical mechanisms to deliver active ingredients throughout the entire lesion.
Doctor-Formulated • FDA Registered
Penetrates Skin Barrier
Breaks through the outer skin barrier that typically blocks topical medications from reaching deeper tissue layers.
Targets Entire Infection
The active ingredient is delivered directly to where bacteria colonize and multiply, attacking the entire infection.
Creates Protective Barrier
Forms a protective layer that continues working to prevent reinfection while the wound heals from within.
Dual-Carrier Penetration System
SkinPass™ utilizes two primary synergistic pharmaceutical carriers that rapidly and efficiently improve transport of active ingredients.
DMSO (Dimethyl Sulfoxide)
DPG (Dipropylene Glycol)
Advanced Biological Coverage (ABC)
ABC is the core mechanism that gives SkinPass™ its exceptional antimicrobial and therapeutic power.
Chemical Mechanism
Chemical Mechanism
Clinically Supported Technology
Physical Mechanism
INFLUX
U.S. Patent 12,465,567
Why this matters
Entire lesion coverage
SkinPass™ helps deliver the active ingredient throughout the entire lesion where bacteria are present.
Outcome
Superior performance
Superior performance against tetracycline-sensitive organisms.
Our Solution
Deep Tissue Penetration
SkinPass™ delivers therapeutic molecules deeper, faster, and more consistently than any single-carrier transdermal system.
Penetration & Distribution
→ DMSO-based carriers penetrate the tissue within 40–60 minutes.
→ Extended diffusion produces uniform distribution across deeper tissue layers.
→ Modeling confirms therapeutic concentrations lasting up to 24 hours.
Clinical Benefits
→ Rapid onset (often within minutes)
→ Increased drug concentration at target depth
→ Enhanced therapeutic effect